Cassava Sciences, Inc.
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

2.005 -

-0.035 (-1.72%)
Range 1.985 - 2.050   (3.27%)
Open 2.050
Previous Close 2.040
Bid Price 2.010
Bid Volume 1,990
Ask Price 2.020
Ask Volume 1,800
Volume 303,944
Value 314,762
Remark -
Delayed prices. Updated at 30 Jan 2026 00:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis